OUR PRODUCTS

MOBILE APPS

GENERAL INFO

XLO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Xilio Therapeutics (XLO) Earnings Date & Reports

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

XLO is expected to report earnings to fall 66.31% to -5 cents per share on November 06

Xilio Therapeutics XLO Stock Earnings Reports

Q3'25

Est.

$-0.05

Q2'25

Missed

by $0.06

Q1'25

Missed

by $0.37

Q4'24

Beat

by $0.06

Q3'24

Beat

by $0.03

The last earnings report on August 14 showed earnings per share of -15 cents, missing the estimate of -10 cents. With 413.08K shares outstanding, the current market capitalization sits at 36.27M.

View a ticker or compare two or three

Compare

XLO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For XLO
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. XLO showed earnings on August 14, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

828 Winter Street

Phone

+1 857 524-2466

Employees

Web

https://www.xiliotx.com